The Limited Times

Now you can see non-English news...

Moscow, agreement to produce 60 million Sputnik doses in China

2021-03-29T09:17:16.119Z


The start of commercial production is scheduled for May (ANSA) The Russian Fund for Direct Investments (Rdif) has announced that it has reached an agreement with the company Shenzhen Yuanxing Gene-Tech for the production in China of more than 60 million doses of the Russian Sputnik V vaccine against Covid-19. Tass reports it. "The volume produced - says Rdif - will allow the vaccination of over 30 million people. The start of commercial production is schedule


The Russian Fund for Direct Investments (Rdif) has announced that it has reached an agreement with the company Shenzhen Yuanxing Gene-Tech for the production in China of more than 60 million doses of the Russian Sputnik V vaccine against Covid-19.

Tass reports it.

"The volume produced - says Rdif - will allow the vaccination of over 30 million people. The start of commercial production is scheduled for May of this year".


Source: ansa

All life articles on 2021-03-29

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.